Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03847922 · ClinicalTrials.gov registry record · Phase 4
Nitrous Oxide for Analgesia During Office Urethral Bulking
A Phase 4 study, sponsored by Baylor Research Institute.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT03847922 is a Phase 4 study that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 2 participants.
The verdict
NCT03847922, a Phase 4 study, was terminated before completion, sponsored by Baylor Research Institute.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study is designed to determine primarily if there is a difference in perceived pain in patients receiving urethral bulking with calcium hydroxylapatite using local lidocaine versus local lidocaine plus nitrous oxide gas. Patients will be randomized to a control group (local lidocaine plus room air) or a intervention group (local lidocaine plus 50% nitrous oxide/50% oxygen inhaled mixture). Their pain will be assessed immediately after the procedure, and their recollection of pain will also be assessed at their 2 week post-procedure visit. There are other secondary outcome measures as well; please see outcome measures section for full description.
Interventions
- OTHER Room air
- DRUG Nitrous Oxide + Oxygen Gas (Product)
- DRUG lidocaine gel 2%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-02-15 |
| Est. Completion | 2020-07-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03847922
The ClinicalTrials.gov registry entry for NCT03847922 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Room air is the first listed.
NCT03847922 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03847922 about?
NCT03847922 is a clinical study titled "Nitrous Oxide for Analgesia During Office Urethral Bulking". This study is designed to determine primarily if there is a difference in perceived pain in patients receiving urethral bulking with calcium hydroxylapatite using local lidocaine versus local lidocaine plus nitrous oxide gas. Patients will be randomized to a control group (local lidocaine plus room ...
What is the current status of trial NCT03847922?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2019-02-15. Estimated completion is 2020-07-23.
What interventions are being tested in trial NCT03847922?
The interventions under investigation include: Room air (OTHER), Nitrous Oxide + Oxygen Gas (Product) (DRUG), lidocaine gel 2% (DRUG).
Who is sponsoring clinical trial NCT03847922?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.